TWIST1 and breast carcinoma: The competitive binding of miR-129-5p to Twist reverses the EMT process of drug-resistant breast cancer cells caused by long noncoding RNAs (lncRNAs), thus improving cell drug sensitivity and slowing migration and invasion [85].